Study of the effects of febuxostat in patients with diabetic nephropathy.
- Conditions
- Diabetic nephropathy
- Registration Number
- JPRN-UMIN000015547
- Lead Sponsor
- Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Not provided
1)Patients with a history of hypersensitivity to febuxostat 2)Patients with secondary hyperuricemia 3)Systolic blood pressure 160 mmHg or higher, or diastolic blood pressure 100 mmHg or more 4)AST or ALT levels are more than double of the normal range 5)Patients who have the following disease were excluded. Non- diabetic chronic kidney disease: glomerulonephritis , renal sclerosis , polycystic kidney disease , inflammatory disease or infection, malignant tumor 6)Patients who develop coronary artery disease , cerebrovascular disease within six months 7)Patients who are administered mercaptopurine hydrate (Roikerin), azathioprine (Imran Azanin) 8)Alcoholics(2 Go / day or more sake in a week average) 9)Patients in Breast-feeding or pregnancy 10)Patients judged by the investigator to be ineligible for some other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method